Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
1 other identifier
interventional
1,000
1 country
1
Brief Summary
Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2022
CompletedFirst Posted
Study publicly available on registry
August 3, 2022
CompletedStudy Start
First participant enrolled
November 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
December 6, 2022
December 1, 2022
5.9 years
August 1, 2022
December 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Positive Predictive Value (PPV)
5 years
Secondary Outcomes (11)
Sensitivity
5 years
Specificity
5 years
Early stage lung cancer detection rate (stage I and II)
5 years
5-year survival rate of patients who have undergone thoracic surgery
5 years
Rate of smoking-related co-morbidities detected on low-dose CT scan
5 years
- +6 more secondary outcomes
Study Arms (1)
CT scan
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Male or female 50-80 years old
- Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)
You may not qualify if:
- Recent history of chest CT scan (within 12 months)
- Person unable to climb 2 floors
- Weight \> 140kg
- Personal history of cancer \< 5 years (currently being monitored by thoracic imaging)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Saint Joseph
Marseille, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arnaud Boyer, MD
Hopital Saint Joseph Marseille
- STUDY DIRECTOR
Illies Bouabdallah, MD
Hopital Saint Joseph Marseille
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2022
First Posted
August 3, 2022
Study Start
November 4, 2022
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2028
Last Updated
December 6, 2022
Record last verified: 2022-12